Pacer Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-862
| Closed | -$20K | – | 2574 |
|
|
2024
Q2 | $20K | Sell |
862
-1,163
| -57% | -$27K | ﹤0.01% | 3409 |
|
|
2024
Q1 | $41.6K | Buy |
+2,025
| New | +$41.6K | ﹤0.01% | 3243 |
|
|
2021
Q2 | – | Sell |
-1,204
| Closed | -$69K | – | 1447 |
|
|
2021
Q1 | $69K | Sell |
1,204
-452
| -27% | -$25.9K | ﹤0.01% | 1379 |
|
|
2020
Q4 | $139K | Sell |
1,656
-214
| -11% | -$18K | ﹤0.01% | 1297 |
|
|
2020
Q3 | $67K | Buy |
+1,870
| New | +$67K | ﹤0.01% | 1291 |
|